And somehow, I mean, it just. It boggles any sensibility somehow. 10 out of the 11 of those people on that advisory panel said no. So I wrote a letter to Janet Woodcock right now, Adelurin has been available under compassionate use, but we're here today because they will no longer have access to it. (00:06–00:11)
CLAIM
Asserts that 10 out of 11 advisory panel members opposed a decision.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.